XCL1 and Duchenne muscular dystrophy: In addition, since AURKA mediated antiapoptosis processes of skeletal muscle cell by regulating XCL1, the selection of WJ-MSCs based on the level of AURKA could be an alternative option to improve their therapeutic efficacy in treating muscle diseases, such as DMD.